AVITA Medical, Inc. (RCEL)
NASDAQ: RCEL · Real-Time Price · USD
10.73
-0.03 (-0.28%)
Sep 3, 2026, 2:32 PM EDT - Market open

AVITA Medical Balance Sheet

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
9.1410.2414.0522.1218.1655.51
Short-Term Investments
27.9421.8466.9461.1829.65
Cash & Short-Term Investments
11.1418.1935.8989.0679.3485.16
Cash Growth
-29.03%-49.32%-59.71%12.24%-6.83%-23.10%
Accounts Receivable
9.879.0911.797.693.533.43
Other Receivables
0.020.020.120.231.180.09
Receivables
9.899.1111.917.924.713.51
Inventory
5.296.937.275.62.132.13
Prepaid Expenses
2.091.271.941.430.921.12
Restricted Cash
-----0.2
Other Current Assets
----0.360
Total Current Assets
28.3935.4957104.0187.4692.13
Property, Plant & Equipment
10.3311.5313.594.322.052.81
Long-Term Investments
----6.9319.69
Other Intangible Assets
5.255.655.570.490.470.44
Long-Term Deferred Charges
-----0.5
Other Long-Term Assets
3.83.733.552.831.360.44
Total Assets
47.7856.3979.71111.6498.26116.02

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
6.428.966.293.7932.71
Accrued Expenses
9.338.0912.558.146.75.36
Current Portion of Long-Term Debt
46.6642.98----
Current Portion of Leases
-0.930.90.90.610.72
Current Unearned Revenue
0.030.030.030.03--
Other Current Liabilities
6.271.680.390.340.380.36
Total Current Liabilities
68.7162.6820.1613.210.699.15
Long-Term Debt
--42.2539.81--
Long-Term Leases
1.822.142.841.70.310.92
Long-Term Unearned Revenue
0.270.290.320.360.70.95
Other Long-Term Liabilities
4.817.949.657.511.830.38
Total Liabilities
75.6273.0475.2162.5813.5211.39

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
000000
Additional Paid-In Capital
399.54394.41367.57350.04339.83332.48
Retained Earnings
-426.68-408.4-359.81-297.97-262.59-235.92
Comprehensive Income & Other
-0.71-2.66-3.26-3.027.58.06
Shareholders' Equity
-27.84-16.654.549.0684.74104.62
Total Liabilities & Equity
47.7856.3979.71111.6498.26116.02

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
48.4846.0545.9942.410.921.64
Net Cash (Debt)
-37.35-27.86-10.146.6585.35103.21
Net Cash Growth
----45.35%-17.30%-5.45%
Net Cash Per Share
-1.25-1.00-0.391.843.414.24
Filing Date Shares Outstanding
30.9330.6326.3625.7125.324.93
Total Common Shares Outstanding
30.9330.5726.3525.6825.2124.93
Working Capital
-40.32-27.1936.8490.8176.7782.99
Book Value Per Share
-0.90-0.540.171.913.364.20
Tangible Book Value
-33.09-22.3-1.0748.5784.28104.18
Tangible Book Value Per Share
-1.07-0.73-0.041.893.344.18
Machinery
6.146.286.23.021.971.88
Construction In Progress
-0.020.440.090.260.03
Leasehold Improvements
4.884.884.610.370.260.24
SEC Filings: 10-K · 10-Q